Amy Reilly
Contacto de Relaciones con Inversores en DYNE THERAPEUTICS, INC. .
Origen de la red de primer grado Amy Reilly.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Holding Company | Pharmaceuticals: Major | 36 | |
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Biotechnology | 22 | |
| Public Company | Medical Specialties | 11 | |
| Subsidiary | Biotechnology | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Amy Reilly a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Director of Finance/CFO General Counsel Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing General Counsel Public Communications Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| TESARO INC | Pharmaceuticals: Major | General Counsel Founder General Counsel Corporate Officer/Principal Chief Administrative Officer | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Chief Executive Officer Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Masters Business Admin | |
| University of Wisconsin | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MODERNA, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Human Resources Officer | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director of Finance/CFO Chief Executive Officer | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| Bentley University | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
| BG MEDICINE, INC. | Medical Specialties | Founder Director of Finance/CFO Corporate Officer/Principal | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder General Counsel | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| SPERO THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member Chief Operating Officer | |
| TREVENA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member Founder Director/Board Member | |
Cadena Bio, Inc.
 Cadena Bio, Inc. Pharmaceuticals: OtherHealth Technology Cadena Bio, Inc. engages in the manufacture of supplements for human health and nutrition by feeding the microbiome. The company was founded in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Other | Director/Board Member President | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
VectorY BV
 VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 44 |
| Alemania | 2 |
| Suiza | 2 |
| Israel | 2 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 35 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operativa
| Director/Board Member | 494 |
| Corporate Officer/Principal | 231 |
| Independent Dir/Board Member | 165 |
| Undergraduate Degree | 87 |
| Founder | 79 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Peter Hutt | 69 |
| John Sculley | 38 |
| Lonnie Moulder | 31 |
| Patrick Volkert Vink | 30 |
| Mark Corrigan | 29 |
| Edward Hurwitz | 27 |
| Sylvie Grégoire | 26 |
| Theo Melas-Kyriazi | 26 |
| Alison Lawton | 25 |
| Jason Rhodes | 24 |
| Bonnie Bassler | 20 |
| Jane Ellen Henney | 20 |
| Tamara Joseph | 19 |
| David Lubner | 19 |
- Bolsa de valores
- Insiders
- Amy Reilly
- Conexiones Empresas
